{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T11:38:55Z","timestamp":1773056335143,"version":"3.50.1"},"reference-count":47,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:00Z","timestamp":1772841600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Acquired epidermodysplasia verruciformis (AEV) is a rare cutaneous disorder arising in immunocompromised individuals. AEV is characterized by flat-topped, wart-like, or hypopigmented lesions predominantly on sun-exposed areas. Unlike classic genetic EV, AEV develops in the absence of germline mutations or family history. AEV most commonly arises in patients receiving iatrogenic immunosuppressive therapy for organ transplantation, autoimmune disease, or hematologic disorders. Methods: A comprehensive literature review was conducted via the PubMed database. Case reports and case series studies describing AEV in transplant and non-transplant iatrogenic immunosuppression were identified through a literature search. There were no restrictions on language or publication year. The last search was conducted in July 2025. Reports were analyzed for patient demographics, immunosuppressive agents, HPV subtypes, clinical and histopathologic features, and treatment outcomes. Results: AEV occurs across a broad spectrum of immunosuppressive therapies, including calcineurin inhibitors, antimetabolites, biologics, tyrosine kinase inhibitors, and cytotoxic chemotherapy. \u03b2-HPV subtypes, most commonly HPV 5 and 8, drive lesion formation in the context of impaired cell-mediated immunity. Histopathology demonstrates keratinocyte vacuolization, acanthosis, and perinuclear halos. Lesions may persist despite immunosuppressive adjustment, due to viral latency and incomplete immune reconstitution. Treatment strategies are varied and include topical retinoids, immune response modifiers, systemic retinoids, and HPV vaccination, and have variable efficacy. AEV carries an elevated risk of cutaneous squamous cell carcinoma, particularly in transplant recipients, and highlights the need for proactive dermatologic management. Conclusions: AEV represents a clinically significant consequence of immunosuppression mediated by \u03b2-HPV. Early recognition, monitoring for malignant transformation, and individualized multimodal therapy are critical. Future studies should evaluate targeted interventions to enhance antiviral immunity and establish standardized treatment guidelines.<\/jats:p>","DOI":"10.3390\/jcm15052049","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T08:58:45Z","timestamp":1773046725000},"page":"2049","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Acquired Epidermodysplasia Verruciformis in Patients with Iatrogenic Immunosuppression"],"prefix":"10.3390","volume":"15","author":[{"given":"Neha S.","family":"Momin","sequence":"first","affiliation":[{"name":"Tilman J. Fertitta Family College of Medicine, University of Houston, Houston, TX 77021, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter L.","family":"Rady","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The University of Texas McGovern Medical School, Houston, TX 77030, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen K.","family":"Tyring","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The University of Texas McGovern Medical School, Houston, TX 77030, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF01938833","article-title":"Ein Fall einer bisher nicht beschriebenen Hauterkrankung (Epidermodysplasia verruciformis)","volume":"141","author":"Lewandowsky","year":"1922","journal-title":"Arch. F\u00fcr Dermatol. Syph."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jaad.2016.12.035","article-title":"Re-evaluation of epidermodysplasia verruciformis: Reconciling more than 90 years of debate","volume":"76","author":"Przybyszewska","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1128\/jcm.33.3.690-695.1995","article-title":"Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients","volume":"33","author":"Berkhout","year":"1995","journal-title":"J. Clin. Microbiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/cup.14333","article-title":"Eosinophilic homogeneous intracytoplasmic inclusion bodies in acquired epidermodysplasia verruciformis-like lesions","volume":"49","author":"Egawa","year":"2022","journal-title":"J. Cutan. Pathol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/ng1044","article-title":"Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis","volume":"32","author":"Ramoz","year":"2002","journal-title":"Nat. Genet."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1084\/jem.20170308","article-title":"The human CIB1\u2013EVER1\u2013EVER2 complex governs keratinocyte-intrinsic immunity to \u03b2-papillomaviruses","volume":"215","author":"Matos","year":"2018","journal-title":"J. Exp. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/ijd.14196","article-title":"A novel approach to the classification of epidermodysplasia verruciformis","volume":"57","author":"Huang","year":"2018","journal-title":"Int. J. Dermatol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"de Jong, S.J., Imahorn, E., Itin, P., Uitto, J., Orth, G., Jouanguy, E., Casanova, J.-L., and Burger, B. (2018). Epidermodysplasia Verruciformis: Inborn Errors of Immunity to Human Beta-Papillomaviruses. Front. Microbiol., 9.","DOI":"10.3389\/fmicb.2018.01222"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jaad.2008.08.035","article-title":"Acquired epidermodysplasia verruciformis","volume":"60","author":"Rogers","year":"2009","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1128\/MMBR.00033-08","article-title":"The EVER proteins as a natural barrier against papillomaviruses: A new insight into the pathogenesis of human papillomavirus infections","volume":"73","author":"Lazarczyk","year":"2009","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Rollison, D.E., Viarisio, D., Amorrortu, R.P., Gheit, T., and Tommasino, M. (2019). An Emerging Issue in Oncogenic Virology: The Role of Beta Human Papillomavirus Types in the Development of Cutaneous Squamous Cell Carcinoma. J. Virol., 93.","DOI":"10.1128\/JVI.01003-18"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1084\/jem.20181207","article-title":"HPV: CIB1 is for EVER and EVER","volume":"215","author":"Notarangelo","year":"2018","journal-title":"J. Exp. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.virusres.2016.11.013","article-title":"The biology of beta human papillomaviruses","volume":"231","author":"Tommasino","year":"2017","journal-title":"Virus Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"5701639","DOI":"10.1155\/2020\/5701639","article-title":"The Role of Beta HPV Types and HPV-Associated Inflammatory Processes in Cutaneous Squamous Cell Carcinoma","volume":"2020","author":"Tampa","year":"2020","journal-title":"J. Immunol. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ctrv.2013.08.005","article-title":"Papillomavirus-associated squamous skin cancers following transplant immunosuppression: One Notch closer to control","volume":"40","author":"Connolly","year":"2014","journal-title":"Cancer Treat. Rev."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00705-004-0398-4","article-title":"UV-B irradiation stimulates the promoter activity of the high-risk, cutaneous human papillomavirus 5 and 8 in primary keratinocytes","volume":"150","author":"Lemme","year":"2005","journal-title":"Arch. Virol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1128\/JVI.00998-10","article-title":"Differential regulation of human papillomavirus type 8 by interferon regulatory factors 3 and 7","volume":"85","author":"Oldak","year":"2011","journal-title":"J. Virol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1111\/ijd.15857","article-title":"Acquired epidermodysplasia verruciformis: Clinical presentation and treatment update","volume":"61","author":"Moore","year":"2022","journal-title":"Int. J. Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"18s","DOI":"10.1038\/jid.1984.15","article-title":"Clinical Observation, Virologic Studies, and Treatment Trials in Patients with Epidermodysplasia Verruciformis, a Disease Induced by Specific Human Papillomaviruses","volume":"83","author":"Lutzner","year":"1984","journal-title":"J. Investig. Dermatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/pde.12734","article-title":"Acquired Epidermodysplasia Verruciformis Associated with Human Papilloma Virus Type 14 in a Small Bowel Transplanted Child\u2014A Case Report","volume":"33","author":"Hirschman","year":"2016","journal-title":"Pediatr. Dermatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1590\/abd1806-4841.20142803","article-title":"Acquired epidermodysplasia verruciformis in a renal transplant recipient\u2014Case report","volume":"89","author":"Mendes","year":"2014","journal-title":"An. Bras. Dermatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/pde.14701","article-title":"Acquired epidermodysplasia verruciformis (AEV) in three children after cardiac transplantation: A case series and review of the literature","volume":"38","author":"Kinariwalla","year":"2021","journal-title":"Pediatr. Dermatol."},{"key":"ref_23","first-page":"S18","article-title":"Acquired epidermodysplasia verruciformis in a renal transplant patient: A case report","volume":"31","author":"Gale","year":"2022","journal-title":"Acta Dermatovenerol. Alp. Pannonica Adriat."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"514","DOI":"10.4067\/s0034-98872024000400514","article-title":"Acquired Epidermodysplasia Verruciformis in a Renal Transplant Patient: Case Report and Literature Review","volume":"152","year":"2024","journal-title":"Rev. Med. Chil."},{"key":"ref_25","first-page":"159","article-title":"Acquired epidermodysplasia verruciformis in a renal transplant recipient","volume":"102","author":"Toribio","year":"2011","journal-title":"Actas Dermo-Sifiliogr\u00e1ficas"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1002\/ccr3.3251","article-title":"Acquired epidermodysplasia verruciformis in renal-transplant recipients","volume":"8","author":"Gara","year":"2020","journal-title":"Clin. Case Rep."},{"key":"ref_27","first-page":"E9","article-title":"Acquired epidermodysplasia verruciformis occurring in a renal transplant recipient","volume":"99","author":"Henley","year":"2017","journal-title":"Cutis"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.ad.2022.11.014","article-title":"Epidermodisplasia verruciforme adquirida en una paciente trasplantada de \u00f3rgano s\u00f3lido","volume":"114","author":"Torre","year":"2023","journal-title":"Actas Dermo-Sifiliogr\u00e1ficas"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ad.2022.01.048","article-title":"Epidermodisplasia verruciforme cong\u00e9nita y adquirida: Serie de 7 casos","volume":"114","author":"Vilardell","year":"2023","journal-title":"Actas Dermo-Sifiliogr\u00e1ficas"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/j.jaad.2006.04.035","article-title":"Epidermodysplasia verruciformis in the setting of graft-versus-host disease","volume":"57","author":"Kunishige","year":"2007","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/1523-1747.ep12285630","article-title":"Human Papillomavirus DNA in Non-melanoma Skin Cancers of a Renal Transplant Recipient: Detection of a New Sequence Related to Epidermodysplasia Verruciformis Associated Types","volume":"108","author":"Bens","year":"1997","journal-title":"J. Investig. Dermatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jdcr.2022.07.021","article-title":"Nonpruritic hypopigmented macules on an immunocompromised patient","volume":"27","author":"Cravero","year":"2022","journal-title":"JAAD Case Rep."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/ajd.12684","article-title":"A case of acquired epidermodysplasia verruciformis in a renal transplant recipient clearing with multimodal treatment including HPV (Gardasil) vaccination","volume":"59","author":"Maor","year":"2018","journal-title":"Australas. J. Dermatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"T110","DOI":"10.1016\/j.ad.2023.10.025","article-title":"Sustained Clinical Response of Acquired Epidermodysplasia Verruciformis to Human Papillomavirus Virus (VPH) Vaccination in a Kidney Transplant Recipient","volume":"115","author":"Quer","year":"2024","journal-title":"Actas Dermo-Sifiliogr\u00e1ficas"},{"key":"ref_35","unstructured":"Safarini, O.A., Keshavamurthy, C., and Patel, P. (2023). Calcineurin Inhibitors. StatPearls, StatPearls Publishing."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/978-3-642-78771-3_6","article-title":"Skin cancer and warts in immunosuppressed renal transplant recipients","volume":"139","author":"Leigh","year":"1995","journal-title":"Recent Results Cancer Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1046\/j.0022-202x.2001.00048.x","article-title":"Human papillomavirus infection and skin cancer risk in organ transplant recipients","volume":"6","author":"Feltkamp","year":"2001","journal-title":"J. Investig. Dermatol. Symp. Proc."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/1523-1747.ep12320803","article-title":"High frequency of detection of epidermodysplasia verruciformis-associated human papillomavirus DNA in biopsies from malignant and premalignant skin lesions from renal transplant recipients","volume":"105","author":"Berkhout","year":"1995","journal-title":"J. Investig. Dermatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1034\/j.1600-0560.2002.290806.x","article-title":"The histologic spectrum of epidermodysplasia verruciformis in transplant and AIDS patients","volume":"29","author":"Morrison","year":"2002","journal-title":"J. Cutan. Pathol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1385\/1-59259-982-6:115","article-title":"HPV DNA Detection and Typing in Inapparent Cutaneous Infections and Premalignant Lesions","volume":"Volume 119","author":"Struijk","year":"2005","journal-title":"Human Papillomaviruses"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2302\/kjm.54.165","article-title":"Mechanisms of UV-induced immunosuppression","volume":"54","author":"Schwarz","year":"2005","journal-title":"Keio J. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/978-3-030-46227-7_10","article-title":"Human Papillomaviruses and Skin Cancer","volume":"Volume 1268","author":"Reichrath","year":"2020","journal-title":"Sunlight, Vitamin D and Skin Cancer; Advances in Experimental Medicine and Biology"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"6502","DOI":"10.1111\/jocd.15253","article-title":"Possible ruxolitinib-induced acquired epidermodysplasia verruciformis and multiple non-melanoma skin cancers in a patient with polycythemia vera","volume":"21","year":"2022","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1525-1470.2012.01822.x","article-title":"Acquired epidermodysplasia verruciformis in a child with atopic dermatitis","volume":"31","author":"Fernandez","year":"2014","journal-title":"Pediatr. Dermatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.jdcr.2018.05.021","article-title":"Acquired epidermodysplasia verruciformis in setting of tumor necrosis factor-\u03b1 inhibitor therapy","volume":"4","author":"Schultz","year":"2018","journal-title":"JAAD Case Rep."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jdcr.2022.11.017","article-title":"Acquired epidermodysplasia verruciformis secondary to methotrexate","volume":"31","author":"AlFada","year":"2023","journal-title":"JAAD Case Rep."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s00277-015-2329-8","article-title":"Acquired epidermodysplasia verruciformis, a new opportunistic infection related to bendamustine","volume":"94","author":"Cougoul","year":"2015","journal-title":"Ann. Hematol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/5\/2049\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T09:23:37Z","timestamp":1773048217000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/5\/2049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,7]]},"references-count":47,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["jcm15052049"],"URL":"https:\/\/doi.org\/10.3390\/jcm15052049","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,7]]}}}